FIL Ltd acquired a new position in 111, Inc. (NASDAQ:YI - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 680,799 shares of the company's stock, valued at approximately $450,000. FIL Ltd owned approximately 7.96% of 111 as of its most recent filing with the Securities and Exchange Commission.
Separately, Napean Trading & Investment Co Singapore PTE Ltd bought a new position in shares of 111 in the fourth quarter worth $245,000. Institutional investors own 21.32% of the company's stock.
Analysts Set New Price Targets
Separately, Weiss Ratings reissued a "sell (e+)" rating on shares of 111 in a report on Tuesday, April 8th.
Check Out Our Latest Stock Report on 111
111 Price Performance
NASDAQ YI traded up $0.19 during trading on Friday, reaching $7.50. The company's stock had a trading volume of 1,855 shares, compared to its average volume of 23,237. The stock has a market capitalization of $64.14 million, a PE ratio of -1.88 and a beta of 0.57. The firm has a fifty day moving average of $8.29 and a 200 day moving average of $7.51. 111, Inc. has a one year low of $4.15 and a one year high of $14.10.
111 (NASDAQ:YI - Get Free Report) last announced its earnings results on Thursday, March 20th. The company reported ($0.04) earnings per share for the quarter. The company had revenue of $527.14 million for the quarter.
About 111
(
Free Report)
111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.
Featured Articles
Before you consider 111, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 111 wasn't on the list.
While 111 currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
